These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11758666)

  • 1. Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.
    Baumann P; Eap CB; Zullino DF
    J Nerv Ment Dis; 2001 Nov; 189(11):798-9. PubMed ID: 11758666
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine for psychosis in Alzheimer's disease.
    Levkovitz Y; Bloch Y; Kaplan D; Diskin A; Abramovitchi I
    J Nerv Ment Dis; 2001 Feb; 189(2):126-9. PubMed ID: 11225688
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-responsive symptoms during early neuroleptic treatment.
    Mazure CM; Nelson JC; Jatlow PI; Bowers MB
    Psychiatry Res; 1992 Feb; 41(2):147-54. PubMed ID: 1574541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy".
    Chiu CC; Lu ML
    J Clin Psychopharmacol; 2005 Dec; 25(6):626-7; author reply 627-8. PubMed ID: 16282861
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.
    Mazure CM; Nelson JC; Jatlow PI; Kincare P; Bowers MB
    J Clin Psychiatry; 1990 Aug; 51(8):330-4. PubMed ID: 2199431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    Hale MS; Bellizzi J
    J Nerv Ment Dis; 1980 May; 168(5):312-4. PubMed ID: 7365497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression.
    Anton RF; Burch EA
    Am J Psychiatry; 1990 Sep; 147(9):1203-8. PubMed ID: 2201223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perphenazine in breast milk and serum.
    Olesen OV; Bartels U; Poulsen JH
    Am J Psychiatry; 1990 Oct; 147(10):1378-9. PubMed ID: 2400007
    [No Abstract]   [Full Text] [Related]  

  • 10. The computer analyzes two psychotherapeutic agents in anxiety-depressed states.
    Falk MA
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):488-99. PubMed ID: 4198312
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood clozapine levels elevated by fluvoxamine: potential for side effects and lower clozapine dosage.
    Armstrong SC; Stephans JR
    J Clin Psychiatry; 1997 Nov; 58(11):499. PubMed ID: 9413421
    [No Abstract]   [Full Text] [Related]  

  • 12. Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Nakayama K; Graff-Guerrero A; Mimura M
    J Alzheimers Dis; 2017; 60(1):263-272. PubMed ID: 28800334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.
    Hansen LB; Larsen NE; Vestergård P
    Psychopharmacology (Berl); 1981; 74(4):306-9. PubMed ID: 6794071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of protriptyline and perphenazine in neurotic depressed outpatients.
    Weinstock R; Fisher S; Spillane J; Ise C; Shaw D; Torop P
    J Clin Pharmacol; 1975; 15(8-9):627-30. PubMed ID: 1097480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.
    Chouinard G; Annable L; Serrano M; Albert JM; Charette R
    Arch Gen Psychiatry; 1975 Oct; 32(10):1295-307. PubMed ID: 1101843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined antidepressant-tranquilizer therapy of mixed psychiatric syndromes.
    Feldman PE
    Psychosomatics; 1965; 6(5):312-5. PubMed ID: 5319240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.